To explore the role of single-atom nanozymes in researching central nervous system diseases and treating injuries.
Investigated the properties of single-atom nanozymes in relation to CNS pathology.
Evaluated the efficacy of nanozymes in mitigating inflammatory damage.
Analyzed effects on neuronal health using in vitro models.
Single-atom nanozymes reduced inflammation significantly in affected models.
Demonstrated improvement in neuronal survival and function after treatment.
Indicated potential as therapeutic agents targeting CNS injuries.
Abstract
Featuring complex neural architectures, the central nervous system (CNS) poses a high risk of irreversible damage or chronic diseases upon injury by inflammatory factors. However, due to the existence of...
Demander à l'IA
Like
Bookmark
Share
View Full Paper
Demander à l'IA
Like
Bookmark
Share
View Full Paper
Single-atom nanozymes: a new platform for central nervous system disease research | Synapse